The financial toxicity of cancer costs STAT ❤️

Financial toxicity of cancer care in low and middleincome

Financial toxicity and implications for cancer care in the

Financial Toxicity and Cancer Treatment PDQ® Health

Financial toxicity in hematological malignancies a

The Financial Burden and Distress of Patients with Cancer

The financial burden and distress of patients with cancer

Navigating financial toxicity in patients with cancer A

Financial Hardship in Survivorship Care Delivery

Addressing Financial Toxicity With Patients and Health Systems

Finanzielle Toxizität einer Krebserkrankung

Society of Behavioral Medicine SBM position statement

Methods for measuring financial toxicity after cancer

Financial Toxicity Among Patients With Breast Cancer

Financial Toxicity and Cancer Treatment PDQ® NCI


28 mars 2018 · In one study of 1,202 adult cancer survivors, 20.4% of the cohort reported experiencing financial difficulties which was defined as being unable to pay for their cancer-related medical bills; having to borrow money; going into debt; filing for bankruptcy; or other financial sacrifices . Patients who were female, between 18–64 years of age, nonwhite, and who were forced to make a change in. 11 of 22 studies examined financial toxicity indirectly by assessing distress financing. 2,15,17–20,25,26,28,32,33. One study examined financial toxicity using Comprehensive Score for Financial Toxicity–Functional Assessment of Chronic Illness Therapy and reported that 52% of the population had considerable financial toxicity. 24. Many studies. 30 nov. 2024 · Financial toxicity describes the financial burden and distress that can arise for patients, and their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for treatment and indirect costs such as travel, time, and changes to employment that can increase the burden of cancer. 31 janv. 2024 · In this article, we propose a four-step approach addressing the issue of FT in patients with cancer: first, acknowledging and understanding the problem; second, quantifying the problem; third, engaging key stakeholders and fostering communication and fourth, implementing solutions at various levels of the healthcare system. 31 janv. 2024 · Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions. EClinicalMedicine. 2024 Jan 31;20:100269. doi: 10.1016/j.eclinm.2024.100269. eCollection 2024 Mar. diagnosis of cancer on the well-being of patients, their families and society. With continued escalation in the costs of cancer treatment, FT has become an important consideration in recent cancer care. In this article, we propose a four-step approach addressing the issue of FT in patients with cancer: first, acknowledging and under-. 30 janv. 2024 · PDF | On Jan 31, 2024, Aakash Desai and others published Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions | Find, read. 31 janv. 2024 · Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions A. DesaiB. Gyawali It is indicated that cancer diagnosis, treatment and care impose high financial toxicity on cancer patients in LMICs. Qinqin ChengWinnie K.W. So Asia-Pacific journal of oncology nursing Taylor Neilson. 7 oct. 2016 · Cancer and its treatment lead to increased financial distress for patients. To the authors' knowledge, to date, no standardized patient-reported outcome measure has been validated to assess this distress. METHODS Patients with AJCC Stage IV solid tumors receiving chemotherapy for at least 2 months were recruited. In this review, the authors discuss the nature of financial toxicity, defined as the objective financial burden and subjective financial distress of patients with cancer, as a result of treatments using innovative drugs and concomitant health services. They discuss coping with financial toxicity by patients and how maladaptive coping leads to. 16 janv. 2018 · Conceptual Framework of Financial Toxicity in the Treatment of Patients With Cancer. Financial toxicity results from both objective financial burden and subjective financial distress. The objective financial burden is due to the direct costs of cancer treatment, which increase over time from diagnosis. This financial burden is. 8 déc. 2017 · The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA A Cancer Journal for Clinicians. 16 janv. 2018 · In this review, the authors discuss the nature of financial toxicity, defined as the objective financial burden and subjective financial distress of patients with cancer, as a result of treatments. Abstract. Purpose: The financial toxicity of cancer care is a source of significant distress for patients with cancer. The purpose of this study is to understand factors associated with financial toxicity in three distinct care systems. 7 avr. 2024 · Our study demonstrates varying aspects of financial burden among patients with cancer in three distinct cancer care sites—an academic medical center, a county hospital system, and a VA cancer clinic—and identifies specific factors that increase financial toxicity. 25 avr. 2024 · In sub-group meta-analyses, the objective financial toxicity was higher among cancer patients with household size of more than four (1.17% [95% CI, 1.03, 1.32]; p = 0.02; I2 = 0%), multiple cycles of chemotherapy (1.94% [95% CI, 1.00, 3.75]; p = 0.05; I2 = 43%) and private health facilities (2.87% [95% CI, 1.89, 4.35]; p < 0.00001; I2 = 26%). Financial toxicity is the adverse impact of a cancer diagnosis on a patient's financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. 1 oct. 2019 · A synthesized understanding of predictors and outcomes of the financial burdens associated with cancer care is needed to underpin strategic responses in oncology care. This study systematically reviewed risk factors and outcomes associated with financial burdens related to cancer treatment. 1 oct. 2019 · Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. 1 Please help EMBL-EBI keep the data flowing to the scientific community!. Financial burden measures analyzed across studies were as follows: (1) direct material financial burdens of cancer treatment, such as higher OOP expenses, examined in 19% of the 74 studies (n514); (2) indirect financial burdens,suchaslostsavings,work,andproductivity,and inadequacyoffinancialresourcestomeetneedsforfood, housing, and transport. 1 oct. 2019 · This study systematically reviewed risk factors and outcomes associated with financial burdens related to cancer treatment. Methods: MEDLINE, Embase, PubMed, PsychINFO, and the Cochrane Library. Financial burdens were most severe early in cancer treatment, did not differ by disease site, and were associated with worse health-related quality of life (HRQoL) and nearly twice the odds of cancer medication nonadherence (pooled OR, 1.70; 95%CI, 1.13-2.56). Only a single study demonstrated an association with increased mortality.